Menu menu
  • Flux RSS
  • Twitter
  • Facebook
  • Google Plus
  • LinkedIn
Newsletter - May 2016

Newsletter - May 2016

Read our latest newsletter: → Marianne (...)

Consult our latest key figures for 2015

Consult our latest key figures for 2015

Year 2015 marked the history of the biocluster in

Genopole's Business Support

Genopole’s Business Support

The leading biotech and biotherapy cluster

The leading biotech and biotherapy cluster

Synthetic and systems biology

Synthetic and systems biology

Our real estate offer

Our real estate offer

A medical environment

A medical environment

All Videos of Biomaths Conference

All Videos of Biomaths Conference

Genobiomedecine, a path toward personalized treatments

Genobiomedecine, a path toward personalized treatments

Agenda

08.09

BIOREGATE. European Regenerative Medicine Forum

Bioregate Forum is a great opportunity to present and discuss your company’s or organisation’s latest achievements in research, innovation, clinical trials or market access approaches. The (...)

Read more

27.06

WIN 2016 Symposium

“Innovative Approaches to Improve Cancer Patient Outcomes” It is the 8th edition of a successful series of symposia organized by the Worldwide Innovative Networking (WIN) Consortium, dedicated to (...)

Read more

12.06

International Congress on Personalized Health Care

Personalized Health Care: From Research to Impact Palais des Congrès de Montréal At the dawn of the twenty-first century, the most recent research in molecular biology, advances in genomics, and (...)

Read more

Live news

  • Genopole

    26 June 2016

    RT @UnivEvry: En direct de la mer de glace avec @Genopole @ENSIIE @TelecomSudParis @TelecomEM et @VilledEvry #projetmontblanc https://t.co…

  • Genopole

    26 June 2016

    RT @Labiotech_eu: #CRISPR in yet another Collaboration - now for Muscle Dystrophy @CRISPRTX #DMD #Duchenne https://t.co/nGqoJ3ngv9 https://…

  • Genopole

    26 June 2016

    RT @Labiotech_eu: Novel Antibiotic for Resistant #bacteria gets a €22M Push from Key Investors #Allecra https://t.co/jonWOKEVWX https://t.c…

  • Genopole

    26 June 2016

    RT @HopkinsMedicine: #Immunotherapy is a groundbreaking treatment that allows the body to use its own immune system to fight #cancer . http…

  • Genopole

    26 June 2016

    Science stars of China https://t.co/r7PLyWLlTK

  • Genopole

    26 June 2016

    Le ver qui rajeunit après avoir vieilli - https://t.co/hYOyk8SP2u

  • Genopole

    26 June 2016

    ‘Undead’ genes come alive days after life ends https://t.co/t0mxVoDbhD

  • Genopole

    25 June 2016

    RT @Limportant_fr: Découverte: des centaines de gènes «zombies» se réactivent après la mort https://t.co/gVa8CCrXkZ https://t.co/RnI1MFGxTl

  • Genopole

    24 June 2016

    RT @BpifranceLeLab: Les #ETI 🇫🇷 confirment que la reprise est là ! Découvrez #EETI2016 de @BpifranceLeLab ! https://t.co/NIh5bxckTY https:/…

  • Genopole

    24 June 2016

    RT @UnivEvry: #ProjetMontBlanc L'aventure commence ! Du 25-29 juin, suivez-nous pour vivre l'expérience en LIVE ! @Genopole https://t.co/oZ…

  • Genopole

    24 June 2016

    RT @buzz4bio: Pall Life Sciences, sponsor Platine de #Bioproduction vol6 @Genopole Merci pour sa fidélité en tant que partenaire ! https://…

  • Genopole

    24 June 2016

    RT @buzz4bio: Déjà 2 stands et 3 présentations d'entreprises en moins pour #Bioproduction vol6 B4B-Connection @Genopole https://t.co/TtKJRm…

  • Global Bioenergies on track with the development schedule of its bio-isobutene production process

    Global Bioenergies, an industrial biology company developing sustainable routes to light olefins, announces significant progress in the development of its process for the production of biological (...)

  • Gene Signal and collaborators demonstrate successful activity of topical aganirsen

    Gene Signal announced the publication of data demonstrating the significant activity of aganirsen (GS-101, eye drop) in two important models of retinal neovascular disease, wet age-related (...)

Sharing expertise, competencies and means

Sharing expertise, competencie

Sharing expertise, competencies and means

The Infrastructures and Platforms Department (...)


Create, Develop, Attract

Create, Develop, Attract

Create, Develop, Attract

The mission of the Genopole Enterprises team (...)